271 related articles for article (PubMed ID: 30433782)
1. 4-Hydroxy-3-nitro-5-ureido-benzenesulfonamides Selectively Target the Tumor-Associated Carbonic Anhydrase Isoforms IX and XII Showing Hypoxia-Enhanced Antiproliferative Profiles.
Nocentini A; Trallori E; Singh S; Lomelino CL; Bartolucci G; Di Cesare Mannelli L; Ghelardini C; McKenna R; Gratteri P; Supuran CT
J Med Chem; 2018 Dec; 61(23):10860-10874. PubMed ID: 30433782
[TBL] [Abstract][Full Text] [Related]
2. Discovery of 4-Hydroxy-3-(3-(phenylureido)benzenesulfonamides as SLC-0111 Analogues for the Treatment of Hypoxic Tumors Overexpressing Carbonic Anhydrase IX.
Bozdag M; Carta F; Ceruso M; Ferraroni M; McDonald PC; Dedhar S; Supuran CT
J Med Chem; 2018 Jul; 61(14):6328-6338. PubMed ID: 29962205
[TBL] [Abstract][Full Text] [Related]
3. Discovery of new ureido benzenesulfonamides incorporating 1,3,5-triazine moieties as carbonic anhydrase I, II, IX and XII inhibitors.
Lolak N; Akocak S; Bua S; Sanku RKK; Supuran CT
Bioorg Med Chem; 2019 Apr; 27(8):1588-1594. PubMed ID: 30846402
[TBL] [Abstract][Full Text] [Related]
4. Dual-tail arylsulfone-based benzenesulfonamides differently match the hydrophobic and hydrophilic halves of human carbonic anhydrases active sites: Selective inhibitors for the tumor-associated hCA IX isoform.
Ibrahim HS; Allam HA; Mahmoud WR; Bonardi A; Nocentini A; Gratteri P; Ibrahim ES; Abdel-Aziz HA; Supuran CT
Eur J Med Chem; 2018 May; 152():1-9. PubMed ID: 29684705
[TBL] [Abstract][Full Text] [Related]
5. Inclusion of a 5-fluorouracil moiety in nitrogenous bases derivatives as human carbonic anhydrase IX and XII inhibitors produced a targeted action against MDA-MB-231 and T47D breast cancer cells.
Petreni A; Bonardi A; Lomelino C; Osman SM; ALOthman ZA; Eldehna WM; El-Haggar R; McKenna R; Nocentini A; Supuran CT
Eur J Med Chem; 2020 Mar; 190():112112. PubMed ID: 32044580
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of a new series of N⁴-substituted 4-(2-aminoethyl)benzenesulfonamides and their inhibitory effect on human carbonic anhydrase cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII.
Sławiński J; Brzozowski Z; Żołnowska B; Szafrański K; Pogorzelska A; Vullo D; Supuran CT
Eur J Med Chem; 2014 Sep; 84():59-67. PubMed ID: 25016228
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and carbonic anhydrase inhibition of a series of SLC-0111 analogs.
Carta F; Vullo D; Osman SM; AlOthman Z; Supuran CT
Bioorg Med Chem; 2017 May; 25(9):2569-2576. PubMed ID: 28347633
[TBL] [Abstract][Full Text] [Related]
8. Novel benzofuran-based sulphonamides as selective carbonic anhydrases IX and XII inhibitors: synthesis and
Abdelrahman MA; Eldehna WM; Nocentini A; Ibrahim HS; Almahli H; Abdel-Aziz HA; Abou-Seri SM; Supuran CT
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):298-305. PubMed ID: 31809607
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of new 3-(2-mercapto-4-oxo-4H-quinazolin-3-yl)-benzenesulfonamides with strong inhibition properties against the tumor associated carbonic anhydrases IX and XII.
Bozdag M; Alafeefy AM; Altamimi AM; Carta F; Supuran CT; Vullo D
Bioorg Med Chem; 2017 May; 25(10):2782-2788. PubMed ID: 28389112
[TBL] [Abstract][Full Text] [Related]
10. Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N'-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
Żołnowska B; Sławiński J; Pogorzelska A; Chojnacki J; Vullo D; Supuran CT
Eur J Med Chem; 2014 Jan; 71():135-47. PubMed ID: 24291567
[TBL] [Abstract][Full Text] [Related]
11. Discovery of curcumin inspired sulfonamide derivatives as a new class of carbonic anhydrase isoforms I, II, IX, and XII inhibitors.
Ramya PVS; Angapelly S; Angeli A; Digwal CS; Arifuddin M; Babu BN; Supuran CT; Kamal A
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1274-1281. PubMed ID: 28965419
[TBL] [Abstract][Full Text] [Related]
12. "A Sweet Combination": Developing Saccharin and Acesulfame K Structures for Selectively Targeting the Tumor-Associated Carbonic Anhydrases IX and XII.
Bua S; Lomelino C; Murray AB; Osman SM; ALOthman ZA; Bozdag M; Abdel-Aziz HA; Eldehna WM; McKenna R; Nocentini A; Supuran CT
J Med Chem; 2020 Jan; 63(1):321-333. PubMed ID: 31794211
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and inhibition potency of novel ureido benzenesulfonamides incorporating GABA as tumor-associated carbonic anhydrase IX and XII inhibitors.
Ceruso M; Antel S; Scozzafava A; Supuran CT
J Enzyme Inhib Med Chem; 2016; 31(2):205-11. PubMed ID: 25792500
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-Activated Prodrug Derivatives of Carbonic Anhydrase Inhibitors in Benzenesulfonamide Series: Synthesis and Biological Evaluation.
Anduran E; Aspatwar A; Parvathaneni NK; Suylen D; Bua S; Nocentini A; Parkkila S; Supuran CT; Dubois L; Lambin P; Winum JY
Molecules; 2020 May; 25(10):. PubMed ID: 32443462
[TBL] [Abstract][Full Text] [Related]
15. Novel sulfonamide bearing coumarin scaffolds as selective inhibitors of tumor associated carbonic anhydrase isoforms IX and XII.
Chandak N; Ceruso M; Supuran CT; Sharma PK
Bioorg Med Chem; 2016 Jul; 24(13):2882-2886. PubMed ID: 27137360
[TBL] [Abstract][Full Text] [Related]
16. Carbonic anhydrase inhibitors: bioreductive nitro-containing sulfonamides with selectivity for targeting the tumor associated isoforms IX and XII.
D'Ambrosio K; Vitale RM; Dogné JM; Masereel B; Innocenti A; Scozzafava A; De Simone G; Supuran CT
J Med Chem; 2008 Jun; 51(11):3230-7. PubMed ID: 18481843
[TBL] [Abstract][Full Text] [Related]
17. Application of hydrazino and hydrazido linkers to connect benzenesulfonamides with hydrophilic/phobic tails for targeting the middle region of human carbonic anhydrases active site: Selective inhibitors of hCA IX.
Allam HA; Fahim SH; F Abo-Ashour M; Nocentini A; Elbakry ME; Abdelrahman MA; Eldehna WM; Ibrahim HS; Supuran CT
Eur J Med Chem; 2019 Oct; 179():547-556. PubMed ID: 31276899
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of coumarin-sulfonamide derivatives and determination of their cytotoxicity, carbonic anhydrase inhibitory and molecular docking studies.
Zengin Kurt B; Sonmez F; Ozturk D; Akdemir A; Angeli A; Supuran CT
Eur J Med Chem; 2019 Dec; 183():111702. PubMed ID: 31542715
[TBL] [Abstract][Full Text] [Related]
19. Kinetic and X-ray crystallographic investigations on carbonic anhydrase isoforms I, II, IX and XII of a thioureido analog of SLC-0111.
Lomelino CL; Mahon BP; McKenna R; Carta F; Supuran CT
Bioorg Med Chem; 2016 Mar; 24(5):976-81. PubMed ID: 26810836
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of coumarin-3-carboxamides as selective carbonic anhydrase IX and XII inhibitors.
Thacker PS; Alvala M; Arifuddin M; Angeli A; Supuran CT
Bioorg Chem; 2019 May; 86():386-392. PubMed ID: 30763885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]